Kelly Blackburn

Kelly Blackburn currently works at Bach Pharma, Inc., as Chief Executive Officer & Director from 2016 and CervoMed, Inc., as Executive Vice President-Clinical Development from 2025.
Ms. Blackburn also formerly worked at Millennium Pharmaceuticals, Inc., as Director-Clinical & Safety Operations from 2002 to 2006, aTyr Pharma, Inc., as Vice President-Clinical Affairs from 2013 to 2016, Vertex Pharmaceuticals, Inc., as Vice President-Clinical Development Operations from 2006 to 2012, and EIP Pharma, Inc., as Senior Vice President-Clinical Development from 2018 to 2023.
Ms. Blackburn received her undergraduate degree from the University of New Hampshire, graduate degree from Quinnipiac College, Inc., and graduate degree from Cambridge College Lima SRL.